{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:36:55Z","timestamp":1791247015833,"version":"4.1.0"},"reference-count":30,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2010,7,9]],"date-time":"2010-07-09T00:00:00Z","timestamp":1278633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcoholism Clin &amp;amp; Exp Res"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> This study evaluated the efficacy of quetiapine versus placebo as an adjunct to lithium or divalproex in reducing alcohol consumption in patients with bipolar I disorder and coexisting alcohol dependence.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Male and female outpatients (21 to 60\u2003years) with a history of bipolar I disorder and alcohol dependence were included in this 12\u2010week, placebo\u2010controlled study. Patients treated with lithium or divalproex (ongoing or assigned at screening) were randomized to receive quetiapine (dosed up to 400\u2003mg\/d over 7\u2003days, followed by 300 to 800\u2003mg\/d flexible dosing until study end) or placebo. The primary outcome measure was the change in the proportion of heavy drinking days from baseline to Week\u200312 (as derived from the Timeline Followback method). Secondary outcome measures included time to the first consecutive 2\u2003weeks of abstinence, changes from baseline to Week\u200312 in the proportion of nondrinking days, mean number of standardized drinks per day, and Clinical Global Impressions\u2010Severity of Illness score.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Of 362 enrolled patients (mean 38.6\u2003years), 176 were randomized to receive quetiapine and 186 to placebo. The mean proportion of heavy drinking days at baseline was 0.66 in the quetiapine group and 0.67 in the placebo group. At Week\u200312, the mean change in the proportion of heavy drinking days was \u22120.36 with quetiapine and \u22120.36 with placebo (<jats:italic>p\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0.93). No statistically significant differences in any of the secondary outcome measures were noted between the quetiapine and placebo groups. The incidence of adverse events was consistent with the previously known tolerability profile of quetiapine.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> The efficacy of quetiapine in the treatment of bipolar disorder is already well established. In this study, however, quetiapine added to lithium or divalproex did not result in significantly greater improvement compared with placebo in measures of alcohol use and dependence in patients with bipolar I disorder and alcohol dependence.<\/jats:p>","DOI":"10.1111\/j.1530-0277.2010.01270.x","type":"journal-article","created":{"date-parts":[[2010,7,12]],"date-time":"2010-07-12T07:11:41Z","timestamp":1278918701000},"page":"1822-1831","source":"Crossref","is-referenced-by-count":65,"title":["A Double\u2010Blind, Placebo\u2010Controlled Study With Quetiapine as Adjunct Therapy With Lithium or Divalproex in Bipolar I Patients With Coexisting Alcohol Dependence"],"prefix":"10.1111","volume":"34","author":[{"given":"Mary","family":"Stedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M.","family":"Pettinati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Sherwood","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Kotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Raines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,7,9]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"American Psychiatric Association(2000)Diagnostic and Statistical Manual of Mental Disorders (DSM\u2010IV) text revision.American Psychiatric Association Washington DC."},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1995.tb01475.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.5.672"},{"key":"e_1_2_8_5_1","first-page":"19","article-title":"The relationship between substance abuse and bipolar disorder","volume":"56","author":"Brady KT","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0502"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2002.02229.x"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(97)00134-7"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-2-29"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2003.00017.x"},{"key":"e_1_2_8_11_1","unstructured":"Depakote [package insert]. North Chicago IL:Abbott Laboratories;2006. Available at:http:\/\/www.rxabbott.com\/pdf\/depakote.pdf. Accessed August 12 2008."},{"key":"e_1_2_8_12_1","first-page":"321","article-title":"Quality of life enjoyment and satisfaction questionnaire: a new measure","volume":"29","author":"Endicott J","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199802000-00009"},{"key":"e_1_2_8_14_1","unstructured":"GuyW(ed). (1976)ECDEU assessment manual for psychopharmacology: publication ADM 76\u2010338. pp.218\u2013222.US Department of Health Education and Welfare Washington DC."},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8341.1959.tb00467.x"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3180ca86e5"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000106230.36344.b1"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.944"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03450190043026"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2004.00115.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.1.37"},{"key":"e_1_2_8_23_1","unstructured":"SheehanDV(1983).The Anxiety Disease.Scribner\u2019s New York NY."},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"e_1_2_8_25_1","unstructured":"SobellLC SobellMB(1996)Timeline FollowBack User\u2019s Guide: A Calendar Method for Assessing Alcohol and Drug Use.Addiction Research Foundation Toronto."},{"key":"e_1_2_8_26_1","unstructured":"SomozaE DyrenforthS GoldsmithJ et\u00a0al.(1995).In search of a universal drug craving scale. Presented at the Annual Meeting of the American Psychiatric Association Miami FL."},{"key":"e_1_2_8_27_1","first-page":"1122","article-title":"Safety of Depakote in bipolar patients with comorbid alcohol abuse\/dependence Valproate for alcoholics with bipolar disorder","volume":"156","author":"Sonne SC","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199406000-00007"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.06.001"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0405"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1530-0277.2010.01270.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1530-0277.2010.01270.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:53:23Z","timestamp":1698713603000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1530-0277.2010.01270.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,9]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1111\/j.1530-0277.2010.01270.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1530-0277.2010.01270.x","archive":["Portico"],"relation":{},"ISSN":["0145-6008","1530-0277"],"issn-type":[{"value":"0145-6008","type":"print"},{"value":"1530-0277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,9]]}}}